Creative Medical Technology Holdings, Inc. (CELZ) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is held by 14 institutional firms.

• The percentage of Creative Medical Technology Holdings owned by institutions changed from 3.5% in September 2025 to 6.3% in December 2025, marking a slight up trend.
• In percentage terms, this reflects as a holdings change of 96.66% quarter on quarter, and an increase of 55.56% year over year.
• Of these 14 institutional investors, 8 increased their holdings in Creative Medical Technology Holdings, while 1 of them reduced positions, and 5 investors maintained their exposure.
• This class of investors increased its holdings in Creative Medical Technology Holdings to 128.86K shares for the 13F-cycle ending December 2025, up by 63.34K shares quarter on quarter, and up 99.00K shares year over year.
• As of December 31, 2025, JANE STREET GROUP, LLC held Creative Medical Technology Holdings's largest shareholding position with over 30.20K shares, representing 1.47% of total outstanding shares.
• Among the most significant buyers of Creative Medical Technology Holdings during December 2025 were JANE STREET GROUP, LLC (30.20K), CITADEL ADVISORS LLC (17.46K), Global Retirement Partners, LLC (7.92K), GEODE CAPITAL MANAGEMENT, LLC (5.21K), BANK OF AMERICA CORP /DE/ (5.00K).
• Leading sellers of Creative Medical Technology Holdings stock in December 2025 included DRW Securities, LLC (4.78K).
• The top 10 institutional holders of Creative Medical Technology Holdings for the quarter ending December 2025 included JANE STREET GROUP, LLC (30.20K), GEODE CAPITAL MANAGEMENT, LLC (28.47K), VANGUARD GROUP INC (25.87K), CITADEL ADVISORS LLC (17.46K), DRW Securities, LLC (10.32K), Global Retirement Partners, LLC (7.92K), BANK OF AMERICA CORP /DE/ (5.13K), Tower Research Capital LLC (TRC) (2.31K), OSAIC HOLDINGS, INC. (1.13K), MORGAN STANLEY (34).